Introduction
On account of a variety of hemostatic agents, adhesives, and sealants, the outcomes of surgery for Acute Stanford type A aortic dissection (ATAAD) repair have improved greatly. BioGlue (Cryolife Kennesaw, Georgia, USA) is an adhesive (independent of the coagulation cascade) which has hemostatic properties and also strengthens and holds tissues together at sites of complex anastomoses1. There are some reports about complications associated with the use of BioGlue, such as acute cerebral embolism1, myocardial infarction2, and pseudoaneurysm3. Here, we report a rare case of a patient with embolism associated with BioGlue after ATAAD repair, treated by cerebral thrombectomy.